Evidence-based hope is letting people know that things are different than they were even 20 years ago. We now know that that with well-managed type 1 or type 2 diabetes, the odds are good you’re going to live a long and healthy life.
read more →
What causes heart disease, why do so many of us have it, how is it different for people with diabetes, and what can we do about it?
read more →
If you or your spouse has diabetes, what are the chances your children will also develop the disease? Dr. David Greene (who lives with type 1) did the research, and some of it may surprise you.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
Diabetes Clinician Nalani Haviland, who also has lived with type 1 diabetes for over 2o years, shares her recent experience with the implantable Eversense CGM.
read more →
